The Cooper Companies, Inc
- Indústria
- Medical Devices
- Bolsa
- EUA
- País / Região
- USA
- Data do IPO
- 30 de dezembro de 1983
- Funcionários
- 15.000
Faixa de valuation composta · conservador $42–$50 / justo $50–$60 / otimista $60–$70. A $65.91, Dentro da faixa de valor intrínseco otimista · muita expectativa já precificada.
Na publicação $62.55 (24 de maio de 2026)
Ainda não há análises sobre este ativo no seu idioma.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Dados da EODHD, apresentados na moeda de reporte; apenas para referência, não constitui recomendação de investimento.
História
Em breveEsta seção está sendo preenchida — volte em breve.
Posição no setor
Em breveEsta seção está sendo preenchida — volte em breve.
